Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today’s pre-market trading after the company announced results from…
IceCure Medical Reports Data From Its Kidney Cancer Clinical Study Presented At Interventional Radiology Conference Dsud Minimally Invasive Approach Results In Shorter Hospitalization And Minor Impact On Renal Function
ICESECRET interim results, as previously announced, demonstrated ProSense® to be safe and effective in treating kidney tumors with 89.5% recurrence-free rateMore data is expected in the fourth quarter of 2024,
Independent Study Results In Japan Demonstrate 0% Breast Cancer Local Recurrence 5 Years Following Treatment With IceCure’s ProSense, Adding To Continued Data Published Globally
Study published in the peer reviewed journal Breast CancerExcellent cosmetic outcomes, high degree of patient satisfaction, and improved quality of life post-cryoablationStrategic distribution partner
Earnings Scheduled For April 3, 2024
Companies Reporting Before The Bell
• Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on revenue of $907.75 million.
IceCure’s Medical’s Study Using ProSense Finds “Cryoablation Allows The Ultimate De-Escalation Of Surgical Therapy For Select Breast Cancer Patients”
Independent study published in Annals of Surgical Oncology concludes cryoablation is an oncologically safe and feasible minimally invasive procedure option in lieu of surgery for patients with early-stage, low-risk
IceCure’s ProSense Deepens Regulatory Approval In India
ProSense® is already marketed and sold in India based on previous regulatory requirements and now has been re-classified due to new regulationsBreast cancer cryoablation is already performed in India with
Crude Oil Surges 2%; Tharimmune Shares Plummet
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday.
The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The S&P 500 also rose, gaining, 0.07% to 4,553.52.
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
IceCure Medical Reports 9-Month GAAP EPS $(0.26), Revenue $1.97M Down From $2.15M YoY
Financial and Operating Results as of and for the Nine Months Ended September 30, 2023For the nine months ended September 30, 2023, the Company reported an 11% increase in ProSense® systems and disposable